Live Events

 

Upcoming Events

February
21
Wed
12:00 PM

Hematopoietic cell transplantation

Refining the Management of CMV in HCT Recipients: What Does the Future Hold?

Salt Lake City

Francisco M. Marty, MD
Harvard Medical School
Dana-Farber Cancer Institute
Brigham and Women's Hospital
Boston Massachusetts

February
22
Thursday
6:30 AM

CAR-T Cell Therapy

Realizing the Promise of CAR-T Cell Therapy for Leukemia and Lymphoma

Salt Lake City

Stephan A. Grupp, MD, PhD
University of Pennsylvania Perelman School of Medicine
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania

February
22
Thursday
12:00PM

Myeloma

Integrated Myeloma Management for Transplant-Eligible Patients: The Conjunction of Novel Therapeutic Platforms, Innovative Agents, and HCT

Salt Lake City

Paul Richardson, MD
Harvard Medical School
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
Boston, Massachusetts

February
23
Friday
12:00 PM

Acute Myeloid Leukemia

Novel Induction Options in AML: Assessing the Implications for HCT-Eligible Patients

Salt Lake City

Jorge E. Cortes
The University of Texas MD Anderson Cancer Center
Houston, Texas

February
24
Saturday
6:30AM

Hodgkin Lymphoma

Treatment Innovation in Hodgkin Lymphoma: Integrating New Therapeutic Options With Autologous Transplant Across Clinical Settings

Salt Lake City

Anas Younes, MD
Memorial Sloan Kettering Cancer Center
New York, New York

February
24
Saturday
12:00PM

Graft-Versus-Host Disease

New Thinking on GVHD Management in HSCT Recipients: Focus on Underlying Immunology and Innovative Therapeutics

Salt Lake City

David Miklos, MD, PhD
Stanford University
Stanford, California

February
27
Tuesday
3:00PM
7:00PM

Asthma

Personalized Care Throughout the Journey of Patients With Asthma: Optimizing Inhaled and Targeted Treatment

Webcast

David A. Beuther, MD, FCCP
National Jewish Health
Denver, Colorado

Michael E. Wechsler, MD
NJH Cohen Family Asthma Institute
National Jewish Health
Denver, Colorado

March
19
Mon
11:30 AM

Hepatocellular Carcinoma

At the Intersection of Local and Systemic Therapy in the Management of Hepatocellular Carcinoma
Preparing for the Next Evolution in Multimodal Treatment

Los Angeles, CA

Riccardo Lencioni, MD, FSIR, EBIR
University of Pisa School of Medicine
Pisa, Italy

March
19
Mon
12:00 PM

Hepatocellular Carcinoma

At the Intersection of Local and Systemic Therapy in the Management of Hepatocellular Carcinoma
Preparing for the Next Evolution in Multimodal Treatment

Webcast

Riccardo Lencioni, MD, FSIR, EBIR
University of Pisa School of Medicine
Pisa, Italy

April
10
Tuesday
5:30PM

Phenylketonuria

The Evolving Role of Current and Novel Therapies in Improving Outcomes in Adults With PKU

Charlotte, NC

Barbara K. Burton, MD
Northwestern University Feinberg School of Medicine
Ann & Robert H. Lurie Children’s Hospital of Chicago
Chicago, Illinois

Nicola Longo, MD, PhD
University of Utah
Salt Lake City, Utah

April
26
Thu
12:00 PM

Interstitial Lung Disease

Achieving Early and Accurate Diagnosis of Interstitial Lung Disease

Washington, DC

Jonathan G. Goldin, MD, PhD
UCLA Medical Center, Santa Monica
Santa Monica, California

David J. Lederer, MD, MS
Columbia University Medical Center
New York, New York

Past Live Events

February
14
Wed
6:00 PM

Head and Neck Cancer

Solving the Multimodal Puzzle of Head & Neck Cancer in the Immunotherapy Era: How Evidence is Driving Practice Changes

Scottsdale, AZ

Ezra Cohen, MD, FRCPC, FASCO
UC San Diego
San Diego Center for Precision Immunotherapy
UC San Diego Moores Cancer Center
La Jolla, California

February
14
Wed
6:30 PM

Head and Neck Cancer

Solving the Multimodal Puzzle of Head & Neck Cancer in the Immunotherapy Era: How Evidence is Driving Practice Changes

Webcast

Ezra Cohen, MD, FRCPC, FASCO
UC San Diego
San Diego Center for Precision Immunotherapy
UC San Diego Moores Cancer Center
La Jolla, California

February
8
Thursday
6:15PM

Genitourinary Cancers

Strengthening Our Grip on Immuno-Oncology in Genitourinary Cancers: Understanding Science Through Stories

San Francisco

Jonathan E. Rosenberg, MD
Memorial Sloan Kettering Cancer Institute
New York, New York

February
8
Thursday
6:15PM

Genitourinary Cancers

A Master Class on Applying Newer Therapies for Renal Cell Carcinoma: Meeting Real Challenges Through the Advanced Disease Continuum

San Francisco

David F. McDermott, MD
Beth Israel Deaconess Medical Center
Dana-Farber Harvard Cancer Center Kidney Cancer Program
Harvard Medical School
Boston, Massachusetts

January
30
Tuesday
3:00PM

Pneumococcal Vaccination

RISE: Raising Immunization RateS for Pneumococcal DiseasE in Adults

Webcast

Thomas M. File, Jr., MD, MSc, MACP, FIDSA, FCCP
Summa Health
Akron, Ohio
Northeast Ohio Medical University
Rootstown, Ohio

January
25
Thursday
6:30PM
January
25
Thursday
7:00PM
January
19
Friday
6:30PM

Pancreatic Cancer

The Quest to Win Through Science in Pancreatic Cancer: From Sequencing Current Options to Testing Novel Approaches

San Francisco

Andrew H. Ko, MD
Helen Diller Family Comprehensive Cancer Center
University of California San Francisco
San Francisco, California

January
18
Thursday
6:30PM

Oncology

New Options, Emerging Combinations in Advanced Hepatocellular Carcinoma: Are Management Approaches Poised for Transformation?

San Francisco

Ghassan Abou-Alfa, MD, MBA
Memorial Sloan Kettering Cancer Center
New York, New York

December
8
Friday
6:00PM

Hemophilia

Illuminating the Role of Shared Decision-Making as the Hemophilia A Management Landscape Continues to Evolve: Progress in Practice

Atlanta

Guy Young, MD
Children's Hospital Los Angeles
University of Southern California Keck School of Medicine
Los Angeles, California

December
8
Friday
6:00PM

Acute Lymphoblastic Leukemia

Redefining Patient Care in Acute Lymphoblastic Leukemia: The Impact of Novel Antibody and Immune Technologies on Clinical Outcomes

Atlanta

Daniel J. DeAngelo, MD, PhD
Harvard Medical School
Dana-Farber Cancer Institute
Boston, Massachusetts

December
8
Friday
12:30PM

Acute Myeloid Leukemia

A Master Class on Building Better Therapy for AML: Making the Most of an Increasing Number of Innovative Options

Atlanta

Harry P. Erba, MD, PhD
University of Alabama at Birmingham
Birmingham, Alabama

December
8
Friday
1:00PM

Acute Myeloid Leukemia

A Master Class on Building Better Therapy for AML: Making the Most of an Increasing Number of Innovative Options

Webcast

Harry P. Erba, MD, PhD
University of Alabama at Birmingham
Birmingham, Alabama

December
8
Friday
12:30PM

Myeloproliferative Neoplasms

Stories From the MPN Casebook: Expert Perspectives on Challenging Treatment Decisions in Polycythemia Vera and Myelofibrosis

Atlanta

Ruben A. Mesa, MD, FACP
Mayo Clinic in Arizona
Phoenix, Arizona

November
10
Friday
12:15PM

Lung Cancer

Addressing Unmet Needs in Lung Cancer With Rational Immunotherapy-Based Approaches: Evidence and Practicalities

National Harbor, MD

Naiyer Rizvi, MD
Columbia University Medical Center
New York, New York

November
8
Wed
3:00PM

Soft Tissue Sarcoma

Contemporary Management Strategies in STS: Targeted and Cytotoxic Treatment Options to Optimize Patient Outcomes

Wailea, HI

Robin L. Jones, MD
Royal Marsden Hospital and Institute of Cancer Research
London, United Kingdom

October
31
Tuesday
7:00 PM

Obesity Management

Navigating the Challenges in Obesity Management: Best Approaches to Engage the Patient and Personalize Care

National Harbor

Ken Fujioka, MD
Scripps Clinic
San Diego, California

October
30
Monday
5:30AM

Interstitial Lung Diseases

Deciphering the Difference Between Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases: Accurate Diagnosis and Optimal Therapy

Toronto

Kevin R. Flaherty, MD, MS
University of Michigan Health System
Ann Arbor, Michigan

October
28
Saturday
6:00PM

Oncologic Emergencies

Oncologic Emergencies in the ED: Recognizing and Managing Adverse Reactions Associated With Modern Cancer Therapies - Essential Guidance for Emergency Medicine Specialists

Washington, DC

Daniel Pallin, MD, MPH
Harvard Medical School
Brigham and Women's Hospital
Boston, Massachusetts

October
21
Saturday
7:30PM

Hepatocellular Carcinoma

The Expanding Role of the Hepatologist in Interdisciplinary Hepatocellular Carcinoma Management: Achieving the Full Potential of Targeted Therapy and Immunotherapy Advances

Washington, DC

Ghassan Abou-Alfa, MD, MBA
Memorial Sloan Kettering Cancer Center
New York, New York

October
9
Monday
6:30PM

Cancer Immunotherapy Biomarkers

The Present and the Future of Cancer Immunotherapy Biomarkers: Challenges, Opportunities, and Implications for Pathologists

National Harbor, MD

David L. Rimm, MD, PhD
Yale University School of Medicine
New Haven, Connecticut

October
9
Monday
7:00PM

Cancer Immunotherapy Biomarkers

The Present and the Future of Cancer Immunotherapy Biomarkers: Challenges, Opportunities, and Implications for Pathologists

Webcast

David L. Rimm, MD, PhD
Yale University School of Medicine
New Haven, Connecticut

October
6
Friday
7:00PM

Cytomegalovirus

CMV in the Transplant Recipient
At the Crossroads of Current Clinical Challenges and Novel Therapeutic Strategies

San Diego

Michael Boeckh, MD, PhD
Fred Hutchinson Cancer Research Center
University of Washington
Seattle, Washington

September
26
Tuesday
6:15PM

Head and Neck Cancer

Understanding the Impact of Immunotherapy on Head and Neck Cancer: A Look at the Science, Practice, and Future of Multimodal Treatment

San Diego

Robert L. Ferris, MD, PhD
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania

September
26
Tuesday
6:15PM

Head and Neck Cancer

Understanding the Impact of Immunotherapy on Head and Neck Cancer: A Look at the Science, Practice, and Future of Multimodal Treatment

Webcast

Robert L. Ferris, MD, PhD
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania

September
24
Sunday
6:15PM
September
16
Saturday
12:00PM

Heart Failure

Master Class on Heart Failure:
Implementing Real-World Experience and New Advances to Reduce Hospitalizations and Costs

Grapevine, Texas

Javed Butler, MD, MBA, MPH
Heart Institute
Stony Brook University
Stony Brook, New York

September
16
Saturday
6:30AM

Lung Cancer

New Options and Evolving Strategies for Hitting the Target in EGFR-Mutant NSCLC: Navigating the Transitions in the EGFR TKI Treatment Landscape in the Era of Precision Oncology

Chicago

Lecia V. Sequist, MD, MPH
Massachusetts General Hospital Cancer Center
Harvard Medical School
Boston, Massachusetts

June
4

Myeloma

Master Class on Myeloma Care: Realizing the Promise of Novel Therapy Across Treatment Settings

Chicago

Sagar Lonial, MD, FACP
Winship Cancer Institute
Emory University School of Medicine
Atlanta, Georgia

June
4

Meeting Real Challenges of Bladder Cancer in the Community: How Advances in Immunotherapy Can Impact Patients & Their Care

Chicago

Robert Dreicer, MD, MS, MACP, FASCO
University of Virginia Cancer Center
Paul Mellon Urologic Cancer Institute
University of Virginia School of Medicine
Charlottesville, Virginia

June
3

Defining the Role of Novel Multikinase Inhibitors and Immunotherapies in Advanced RCC: Key Advances and Current Impact on Patient Care

Chicago

David F. McDermott, MD
Beth Israel Deaconess
Medical Center
Dana Farber Harvard
Cancer Center
Kidney Cancer Program
Harvard Medical School
Boston, Massachusetts

June
3

Ovarian Cancer

New Horizons in Managing Advanced Ovarian Cancer: Diagnostic Strategies, Novel Therapies, and Patient-Centered Treatment Decisions

Chicago

Bradley J. Monk, MD, FACS, FACOG
Arizona Oncology (US Oncology Network)
University of Arizona College of Medicine - Phoenix
Creighton University School of Medicine at
St. Joseph's Hospital
Phoenix, Arizona

June
2

NSCLC

At the Crossroads of Evidence-Based NSCLC Care: Navigating Current and Emerging Treatment Pathways

Chicago

D. Ross Camidge, MD, PhD
University of Colorado Cancer Center
Aurora, Colorado

June
2

Hepatocellular Carcinoma

Looking to the Future in Hepatocellular Carcinoma: A Master Class on Current & Emerging Therapeutic Strategies

Chicago

Anthony El-Khoueiry, MD
USC Norris Comprehensive Cancer Center
Los Angeles, California

June
2

Prostate Cancer

Science and Stories: Making the Most of the Complex Treatment Landscape in Prostate Cancer

Chicago

Robert Dreicer, MD, MS, MACP, FASCO
University of Virginia Cancer Center
Paul Mellon Urologic Cancer Institute
University of Virginia School of Medicine
Charlottesville, Virginia

May
24

Multiple Sclerosis

Guiding Patients Through the Risks and Benefits of Disease-Modifying Therapy: Patient Stories of Shared Decision-Making Throughout the Course of Multiple Sclerosis

New Orleans

Edward J. Fox, MD, PhD
MS Clinic of Central Texas
Central Texas Neurology Consultants
Round Rock, Texas

May
23

Idiopathic Pulmonary Fibrosis

Understanding and Implementing New Advances in Idiopathic Pulmonary Fibrosis Management: Practical Guidance for Everyday Care

Washington

Steven D. Nathan, MD
Inova Fairfax Hospital
Virginia Commonwealth University-Inova Fairfax Campus
Falls Church, Virginia

May
14

Leukemia

Exploring the CLL Treatment Tool Kit: A Master Class on Modern Therapy, Clinical Trials, and Precision Medicine

New York

William G. Wierda, MD, PhD
The University of Texas
MD Anderson Cancer Center
Houston, Texas

May
13

Prostate Cancer

Urologists at the Intersection of Evidence-Based and Patient-Centric Prostate Cancer Care: Practical Guidance for Everyday Practice

Boston

Robert Dreicer, MD, MS, FACP, FASCO
University of Virginia Cancer Center
Paul Mellon Urologic Cancer Institute
University of Virginia School of Medicine
Charlottesville, Virginia

May
7

Myeloproliferative Neoplasms

The Nurse Casebook on Myeloproliferative Neoplasms: Living the Oncology Nurse Experience

Denver

Jean A. Ridgeway, DNP, APN, NP-C, AOCN
The University of Chicago Medicine Chicago, Illinois

May
6

Acute Myeloid Leukemia

The Oncology Nurse Takes On AML: Insights on Recent Therapeutic Advances and Improving Patient Care

Denver

Sara M. Tinsley, PhD, ARNP, AOCN
Moffitt Cancer Center
University of South Florida, College of Nursing
Tampa, Florida

May
6

Acute Myeloid Leukemia

The Oncology Nurse Takes On AML: Insights on Recent Therapeutic Advances and Improving Patient Care

Webcast

Sara M. Tinsley, PhD, ARNP, AOCN
Moffitt Cancer Center
University of South Florida,
College of Nursing
Tampa, Florida

May
5

Pancreatic Cancer

Breaking the Barriers to Patient-Centric Pancreatic Cancer Care: Nurses Transforming Practice From the Front Lines

Denver

Gayle Jameson, MSN, ACNP-BC, AOCN
HonorHealth Research Institute
Scottsdale, Arizona

May
2

Chronic Heart Failure

A Master Class in Understanding and Applying Updated Treatment Guidelines and Scientific Advances to Reduce Mortality and Hospitalizations in Chronic Heart Failure Patients

Las Vegas

Alpesh Amin, MD, MBA, MACP, SFHM
University of California, Irvine
Irvine, California

April
30

Kidney Transplantation

Preventing DSA-Mediated Renal Allograft Injury: Practical Strategies to Maintain Adequate Immunosuppression in Individual Patients

Chicago

Stanley C. Jordan, MD, FASN
David Geffen School of Medicine at UCLA
Cedars-Sinai Medical Center
Los Angeles, California

April
1

Oncology

New Concepts in Immunotherapy for Solid Tumors: Novel Immune Approaches, Biomarkers, & Immune-Based Combinations

Washington

Naiyer Rizvi, MD
Columbia University Medical Center
New York, New York

April
1

Oncology

New Concepts in Immunotherapy for Solid Tumors: Novel Immune Approaches, Biomarkers, & Immune-Based Combinations

Webcast

Naiyer Rizvi, MD
Columbia University Medical Center
New York, New York

March
21

Gaucher Disease Type 1

Strengthening the Genetics-Hematology Partnership to Shorten the Path to Diagnosis & Treatment of Gaucher Disease Type 1: A Patient Story

Phoenix

Michele Spencer-Manzon, MD, FABMG
Yale School of Medicine
New Haven, Connecticut

February
24

Leukemia

Maximizing Outcomes With Allogeneic HCT in AML: Insight on the Impact of Novel Therapy

Orlando

Jeffrey E. Lancet, MD
Moffitt Cancer Center
Tampa, Florida

February
24

Merkel Cell Carcinoma

Progress-in-Practice Master Class The Coming-of-Age of Immunotherapy in Merkel Cell Carcinoma: Rationale, Evidence, and Practicalities

Orlando

Prof. Jürgen C. Becker, MD, PhD
German Consortium for
Translational Cancer Research - DKTK
University Hospital Essen
University Duisburg-Essen
Essen, Germany

February
24

Myelofibrosis

Maximizing Patient Outcomes in Myelofibrosis: Stem Cell Transplantation in the JAK Inhibitor Era

Orlando

Nicolaus Kröger, MD
University Hospital Hamburg-Eppendorf
Hamburg, Germany

February
23

Hodgkin Lymphoma

Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics

Orlando

Anas Younes, MD
Memorial Sloan Kettering Cancer Center
Weill-Cornell Medical College
New York, New York

February
23

Myeloma

Autologous Transplant in the Era of Novel Therapy in Myeloma: Using Innovative Concepts to Maximize Patient Outcomes

Orlando

Kenneth C. Anderson, MD
Harvard Medical School
Dana-Farber Cancer Institute
Boston, Massachusetts

February
22

Hematopoietic Stem Cell Transplantation

Preventing and Managing Cytomegalovirus and Invasive Fungal Infection After Hematopoietic Stem Cell Transplantation: Key Questions, Expert Answers

Orlando

Dimitrios P. Kontoyiannis, MD, ScD, FACP, FIDSA, FECMM
The University of Texas
MD Anderson Cancer Center
Baylor College of Medicine
University of Houston
Houston, Texas

February
16

RCC

Taking the Leap Into a New Era of Anti-Tumor Efficacy in Advanced RCC: How to Optimize Selection and Sequencing of Therapies Throughout the Disease Continuum

Orlando

Toni Choueiri, MD
Harvard Medical School
Dana-Farber Cancer Institute
Boston, Massachusetts

February
16

Bladder Cancer

Filling the Void in Bladder Cancer: How Immune Checkpoint Inhibition Advances Our Understanding of Disease Biology and Therapy

Orlando

Robert Dreicer, MD, MS, FACP, FASCO
University of Virginia Cancer Center
University of Virginia School of Medicine
Charlottesville, Virginia